Dr. Chan Wai Nok - General Practice
General Practice
Highlights
- MCHK RegisteredVerified
- QualificationsBachelor of Medicine and Bachelor of Surgery (MBChB) · Medical degree 2025
- InsuranceBeing compiled｜See details
About
Dr. Chan Wai Nok is a registered medical practitioner in Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)2025
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Chan Wai Nok? Claim page and update insurance →
FAQ
Is Dr. Chan Wai Nok any good?
Dr. Chan Wai Nok is a registered medical practitioner in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Chan Wai Nok do?
Dr. Chan Wai Nok practises in General Practice.
Are you Dr. Chan Wai Nok? Claim this page to update and manage.
ClaimResearch and publications
9 papers
- Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.Signal transduction and targeted therapy · 2024
- H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling.Clinical and translational medicine · 2023
- The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.Clinical and translational medicine · 2023
- Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.The Journal of pathology · 2023
- Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.International journal of cancer · 2023
- Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway.Cancer letters · 2022
- Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.International journal of cancer · 2022
- Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside.Biomedicines · 2022
- STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker.Molecular cancer · 2021
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer